Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on ...

In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...

Lenacapavir, the injectable drug developed by a US-based company, Gilead Sciences, was trialled (tested) in Uganda and South ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

South Africa’s leadership of the G20 this year is critical for global public health, as it works to tackle the inequalities ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Mathematical models indicate that the worst-case scenario of the Trump administration’s HIV-related cuts could result in 3 ...

With South Africa’s HIV prevalence currently estimated at 12.7%, major strides continue to be made to tackle the epidemic. Significant developments in treatment, preventive measures, and public ...